News & Press: General News

NCATS Funding Opportunities Deadlines

Tuesday, August 23, 2016   (0 Comments)
Posted by: Whitney Lingafelter
Share |

Deadlines to Apply for NCATS Funding Opportunities are Coming Up September 6!

This is a reminder that the National Center for Advancing Translational Sciences (NCATS) has several open Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program funding opportunities designed to help advance and commercialize translational research technologies. NCATS encourages applications in these four research areas of interest: drug discovery and development, diagnostics and devices, bioinformatics and information technology, and clinical research.

All opportunities below have an application deadline of Sept. 6, 2016, 5 p.m. local time.

2016 Omnibus Solicitation

Small businesses, research and technology transfer organizations are eligible to apply for the 2016 Omnibus Solicitation. Applications may address any stage of translation, from target validation through pre-clinical and clinical evaluation to intervention, implementation and dissemination. Review NCATS’ research priorities to determine its areas of interest.

Other Funding Opportunities
SBIR Direct Phase II
Small businesses that have accomplished the objectives of a Phase I SBIR grant through non-SBIR funds are able to apply for SBIR direct-to-Phase II funding. Applicants must demonstrate the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential.

  • PAR-15-288: Direct Phase II SBIR Grants to Support Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science
  • PAR-14-088: Direct Phase II SBIR Grants to Support Biomedical Technology Development

SBIR Technology Transfer
This funding opportunity encourages SBIR grant applications from small business concerns for projects to transfer technology out of the NIH intramural research labs into the private sector.

  • PA-15-354: SBIR Technology Transfer (R43/R44)

Platform Delivery Technologies for Nucleic Acid Therapeutics
This funding opportunity is designed to incentivize small businesses to generate new technologies and products for delivering nucleic acids into cells and tissues for the purpose of treatment or prevention of human disease.

  • PA-14-307: Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
  • PA-14-308: Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)

Development of Appropriate Pediatric Formulations and Drug Delivery Systems
Applications must address different and complementary research needs for the development of appropriate pediatric drug formulations in different age groups.

  • PAR-13-345: Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)
  • PAR-13-346: Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41)

Learn more about current funding opportunities for small business at NCATS Small Business, including eligibility requirements and research priorities. Need help? Contact NCATS SBIR and STTR to discuss your project idea.